StocksFundsScreenerSectorsWatchlists
BRKR

BRKR - Bruker Corp Stock Price, Fair Value and News

78.52USD-4.42 (-5.33%)Market Closed

Market Summary

BRKR
USD78.52-4.42
Market Closed
-5.33%

BRKR Stock Price

View Fullscreen

BRKR RSI Chart

BRKR Valuation

Market Cap

10.8B

Price/Earnings (Trailing)

25.3

Price/Sales (Trailing)

3.65

EV/EBITDA

16.57

Price/Free Cashflow

44.45

BRKR Price/Sales (Trailing)

BRKR Profitability

Operating Margin

51.05%

EBT Margin

18.36%

Return on Equity

31.02%

Return on Assets

10.05%

Free Cashflow Yield

2.25%

BRKR Fundamentals

BRKR Revenue

Revenue (TTM)

3.0B

Rev. Growth (Yr)

20.62%

Rev. Growth (Qtr)

15.04%

BRKR Earnings

Earnings (TTM)

427.2M

Earnings Growth (Yr)

110.99%

Earnings Growth (Qtr)

133.26%

Breaking Down BRKR Revenue

Last 7 days

-13.0%

Last 30 days

-14.6%

Last 90 days

9.2%

Trailing 12 Months

-5.2%

How does BRKR drawdown profile look like?

BRKR Financial Health

Current Ratio

1.8

Debt/Equity

0.84

Debt/Cashflow

0.3

BRKR Investor Care

Dividend Yield

0.25%

Dividend/Share (TTM)

0.2

Buy Backs (1Y)

6.17%

Diluted EPS (TTM)

2.91

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20232.6B2.7B2.8B3.0B
20222.5B2.5B2.5B2.5B
20212.1B2.3B2.4B2.4B
20202.0B2.0B2.0B2.0B
20191.9B2.0B2.0B2.1B
20181.8B1.8B1.9B1.9B
20171.6B1.7B1.7B1.8B
20161.6B1.6B1.6B1.6B
20151.7B1.7B1.7B1.6B
20141.9B1.9B1.9B1.8B
20131.8B1.8B1.8B1.8B
20121.7B1.7B1.7B1.8B
20111.4B1.5B1.6B1.7B
20101.2B1.2B1.3B1.3B
20090001.1B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Bruker Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 04, 2024
requardt hermann fritz
sold
-1,350,900
90.0599
-15,000
-
Mar 04, 2024
requardt hermann fritz
acquired
330,750
22.05
15,000
-
Feb 28, 2024
busse falko
sold
-2,403,890
85.4808
-28,122
president, biospin group
Feb 28, 2024
busse falko
acquired
739,156
26.2839
28,122
president, biospin group
Feb 22, 2024
prause burkhard
sold
-1,276,070
83.3
-15,319
pres. & ceo, bruker best
Feb 22, 2024
prause burkhard
acquired
235,292
43.1728
5,450
pres. & ceo, bruker best
Jan 05, 2024
requardt hermann fritz
acquired
-
-
2,377
-
Jan 05, 2024
rosenthal bob
acquired
-
-
2,377
-
Jan 05, 2024
packer richard a
acquired
-
-
2,377
-
Jan 05, 2024
ma philip
acquired
-
-
2,377
-

1–10 of 50

Which funds bought or sold BRKR recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 17, 2024
NEW MEXICO EDUCATIONAL RETIREMENT BOARD
added
1.96
-162,000
1,337,000
0.05%
Apr 17, 2024
Portside Wealth Group, LLC
added
4.45
102,955
409,955
0.08%
Apr 16, 2024
MinichMacGregor Wealth Management, LLC
new
-
7,892,690
7,892,690
2.02%
Apr 16, 2024
Trifecta Capital Advisors, LLC
sold off
-100
-4,556
-
-%
Apr 16, 2024
OneAscent Wealth Management LLC
new
-
210,000
210,000
0.08%
Apr 16, 2024
OneAscent Financial Services LLC
added
5.36
79,000
305,000
0.03%
Apr 16, 2024
PineStone Asset Management Inc.
reduced
-0.3
3,315,800
15,392,800
0.24%
Apr 15, 2024
Pallas Capital Advisors LLC
added
12.52
271,500,000
890,595,000
37.08%
Apr 15, 2024
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
new
-
353,496
353,496
-%
Apr 12, 2024
AdvisorNet Financial, Inc
sold off
-100
-955
-
-%

1–10 of 48

Are Funds Buying or Selling BRKR?

Are funds buying BRKR calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own BRKR
No. of Funds

Unveiling Bruker Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
t. rowe price investment management, inc.
9.5%
13,192,344
SC 13G/A
Feb 13, 2024
vanguard group inc
7.15%
9,896,786
SC 13G/A
Feb 09, 2024
massachusetts financial services co /ma/
5.8%
8,080,071
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Jan 26, 2024
blackrock inc.
7.1%
9,822,776
SC 13G/A
Feb 14, 2023
t. rowe price investment management, inc.
11.1%
16,368,144
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
7.51%
11,045,016
SC 13G/A
Feb 08, 2023
massachusetts financial services co /ma/
5.1%
7,513,039
SC 13G
Jan 31, 2023
blackrock inc.
7.6%
11,118,621
SC 13G/A

Recent SEC filings of Bruker Corp

View All Filings
Date Filed Form Type Document
Apr 02, 2024
8-K
Current Report
Mar 12, 2024
4
Insider Trading
Mar 06, 2024
4
Insider Trading
Mar 04, 2024
144
Notice of Insider Sale Intent
Mar 01, 2024
4
Insider Trading
Feb 29, 2024
10-K
Annual Report
Feb 28, 2024
144
Notice of Insider Sale Intent
Feb 26, 2024
4
Insider Trading
Feb 22, 2024
144
Notice of Insider Sale Intent
Feb 14, 2024
SC 13G/A
Major Ownership Report

Peers (Alternatives to Bruker Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
182.6B
40.1B
-6.98% -6.26%
31.91
4.55
-8.12% -17.45%
67.4B
19.5B
-2.95% -9.93%
53.63
3.46
4.02% -22.04%
22.6B
3.9B
-4.96% -15.40%
50.88
5.86
3.42% 23.09%
20.1B
14.8B
-5.44% -9.06%
7.58
1.36
2.12% 209.17%
MID-CAP
9.2B
3.5B
-0.25% 17.23%
32.29
2.63
4.97% 18.89%
9.0B
12.3B
-5.97% -15.68%
21.61
0.73
-2.44% -22.68%
8.2B
2.7B
-16.50% -42.23%
-12.88
3.07
-4.68% 82.43%
6.3B
4.0B
-8.09% -25.03%
-46.91
1.59
1.10% 85.84%
3.4B
366.4M
-2.40% 13.34%
-563.48
9.33
33.86% 89.83%
2.3B
6.6B
-5.10% -3.56%
11.8
0.35
2.78% -0.87%
SMALL-CAP
1.2B
3.2B
-10.67% -21.18%
-1.84
0.39
7.73% -1066.14%
378.4M
166.7M
0.43% -6.80%
-4.58
2.27
6.67% -456.34%
245.1M
324.0M
10.27% -31.54%
-1.27
0.76
-3.19% -337.41%
47.5M
52.3M
-23.89% -53.56%
-2.54
0.91
17.61% 19.28%
3.7M
3.7M
-12.80% 240.48%
-0.31
1
5.77% 8.23%

Bruker Corp News

Latest updates
Yahoo Movies Canada27 hours ago
Yahoo Finance05 Mar 202408:00 am

Bruker Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue15.0%855743682685708639588595684609571555628511425424600521490461554
Cost Of Revenue17.8%424360341326343304290289342300290276315263238232304267260247281
Gross Profit12.4%430383341360366335298306342309281279313248186192296254230215273
Operating Expenses26.5%327258254237235204224210216196195190200167148176179166177173166
  S&GA Expenses18.9%211178178163165145152146153141135132130115102121130125125120117
  R&D Expenses17.1%84.0071.0071.0069.0064.0056.0060.0057.0058.0052.0056.0055.0057.0048.0044.0049.0047.0046.0049.0046.0045.00
EBITDA Margin-0.23*-0.20*0.21*0.21*0.21*0.20*0.21*0.21*0.21*0.20*0.19*0.17*--------
Income Taxes20.5%37.0031.0020.0030.0023.0041.0020.0032.0044.0021.0021.0028.0034.0020.007.003.0042.0022.0011.008.0022.00
Earnings Before Taxes102.1%24111978.0010712112970.0094.0012010980.0085.0010675.0031.0014.0011183.0048.0038.00100
EBT Margin21.9%0.18*0.15*0.16*0.16*0.16*0.16*0.16*0.16*0.16*0.16*0.15*0.14*---------
Net Income133.3%20688.0057.0077.0097.0088.0050.0062.0076.0087.0058.0057.0069.0054.0024.0011.0069.0061.0037.0031.0078.00
Net Income Margin27.3%0.14*0.11*0.12*0.12*0.12*0.11*0.11*0.11*0.11*0.11*0.10*0.10*---------
Free Cashflow911.6%17417.00-10.5063.0013712.00-62.3059.001108.00-0.7073.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets11.3%4,2503,8203,8573,7643,6123,3373,3853,5513,6503,1283,0873,0353,0492,8792,9432,9622,7722,3522,3502,2432,129
  Current Assets6.6%2,1642,0292,1832,1332,1132,0372,0882,2512,4721,9891,9681,9461,9251,8261,9571,9901,7961,4341,4061,3441,304
    Cash Equivalents34.3%4883645755986466297268201,072577612700686571750799682300287303326
  Inventory5.7%968916915859800750759740710733730701692696665626577587595542510
  Net PPE13.8%600527523511487422395404406389398384396355336319306278282268271
  Goodwill3.8%5835615585274583823963843403243153133203132952902932822856.00276
Liabilities-2,837---2,480----------------
  Current Liabilities12.1%1,2021,0721,0511,049914865818881939921955944792683750766646643641633599
  Long Term Debt5.6%1,1601,0991,1231,1091,2011,1371,1711,2051,222718721716842828924915813519494332323
    LT Debt, Non Current5.6%1,1601,0991,1231,1091,2011,1371,1711,2051,222718721716842828924915813519494-323
Shareholder's Equity13.9%1,3771,2091,2511,1991,1149489841,0311,0851,0901,015982974963907925917855870922905
  Retained Earnings-2,324---1,926---1,660---1,407---1,275---1,103
  Additional Paid-In Capital-283---256---238---216---200---177
Shares Outstanding-0.5%145146147147147147148149151152151152---------
Minority Interest-4.9%17.0018.0020.0019.0012.0011.0014.0014.0014.0014.0013.0014.0013.0011.009.009.0010.0010.009.008.009.00
Float---6,099---4,001---4,040---2,173---5,068--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations366.0%205,50044,10013,00087,500171,50069,500-44,40077,800138,60023,90021,90098,000203,00082,40011,80035,000136,20052,40010,60014,200132,300
  Share Based Compensation8.8%6,2005,7005,6006,5004,7005,3009,7008,0005,3004,2003,9003,8005,1004,5003,1003,300-5004,0003,0003,1003,100
Cashflow From Investing76.3%-36,800-155,000-26,000-108,200-149,300-57,60057,100-101,800-48,600-48,400-71,400-24,000-28,800-48,200-15,100-100,600-39,200-12,600-79,900-26,700-156,300
Cashflow From Financing35.2%-59,900-92,500-10,300-30,700-36,100-82,000-79,800-217,400404,300-2,600-44,900-38,100-74,300-225,500-53,100191,300277,900-19,50050,400-8,80076,600
  Dividend Payments-1.4%7,3007,4007,3007,4007,4007,4007,5007,5006,0006,1006,0006,1006,1006,2006,1006,2006,2006,2006,3006,3006,300
  Buy Backs-37.2%50,40080,30010022,30025,55072,40060,300105,60082,200-38,30032,80068,8005,00050,000--42,300100,000--

BRKR Income Statement

2023-12-31
Statement - CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Total revenue$ 2,964.5$ 2,530.7$ 2,417.9
Total cost of revenue1,451.21,225.01,208.3
Gross profit1,513.31,305.71,209.6
Operating expenses:   
Selling, general and administrative729.4607.4561.2
Research and development294.8235.9220.8
Other charges, net52.229.714.3
Total operating expenses1,076.4873.0796.3
Operating income436.9432.7413.3
Bargain purchase gain144.10.00.0
Interest and other income (expense), net(36.8)(18.8)(19.7)
Income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries544.2413.9393.6
Income tax provision117.7116.4113.0
Equity in income of unconsolidated investees, net of tax2.01.00.0
Consolidated net income428.5298.5280.6
Net income attributable to noncontrolling interests in consolidated subsidiaries1.31.93.5
Net income attributable to Bruker Corporation$ 427.2$ 296.6$ 277.1
Net income per common share attributable to Bruker Corporation shareholders:   
Basic$ 2.92$ 2$ 1.83
Diluted$ 2.9$ 1.99$ 1.81
Weighted average common shares outstanding:   
Basic146.4148.6151.4
Diluted147.2149.4152.9
Product   
Total revenue$ 2,457.6$ 2,109.9$ 2,017.3
Total cost of revenue1,165.2984.0979.3
Service   
Total revenue493.8414.6393.2
Total cost of revenue285.9240.8228.2
Other   
Total revenue13.16.27.4
Total cost of revenue$ 0.1$ 0.2$ 0.8

BRKR Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 488.3$ 645.5
Accounts receivable, net492.0472.7
Inventories968.3800.1
Assets held for sale0.01.4
Other current assets215.6193.5
Total current assets2,164.22,113.2
Property, plant and equipment, net599.7487.0
Goodwill582.6457.6
Intangible assets, net330.5270.9
Operating lease assets91.751.2
Deferred tax assets297.276.8
Other long-term assets184.0155.1
Total assets4,249.93,611.8
Current liabilities:  
Current portion of long-term debt121.218.7
Accounts payable202.7178.4
Deferred revenue and customer advances400.0370.2
Other current liabilities478.2347.0
Total current Liabilities1,202.1914.3
Long-term debt1,160.31,200.5
Long-term deferred revenue and customer advances91.5101.6
Deferred tax liabilities67.762.3
Operating lease liabilities74.834.8
Accrued pension76.645.7
Other long-term liabilities163.6120.8
Total Liabilities2,836.62,480.0
Commitments and contingencies (Note 18)
Redeemable noncontrolling interests18.76.1
Shareholders' equity:  
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding at December 31, 2023 and 20220.00.0
Common stock, $0.01 par value 260,000,000 shares authorized, 175,943,705 and 175,389,586 shares issued and 145,164,826 and 147,023,144 outstanding at December 31, 2023 and 2022, respectively1.71.7
Treasury stock at cost, 30,778,879 and 28,366,442 shares at December 31, 2023 and 2022, respectively(1,237.2)(1,085.0)
Additional paid-in capital282.9256.3
Retained earnings2,323.81,926.0
Accumulated other comprehensive income, net of tax6.014.8
Total shareholders' equity attributable to Bruker Corporation1,377.21,113.8
Noncontrolling interests in consolidated subsidiaries17.411.9
Total shareholders' equity1,394.61,125.7
Total liabilities, redeemable noncontrolling interest and shareholders' equity$ 4,249.9$ 3,611.8
BRKR
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
 CEO
 WEBSITEbruker.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES8525

Bruker Corp Frequently Asked Questions


What is the ticker symbol for Bruker Corp? What does BRKR stand for in stocks?

BRKR is the stock ticker symbol of Bruker Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Bruker Corp (BRKR)?

As of Thu Apr 18 2024, market cap of Bruker Corp is 10.81 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BRKR stock?

You can check BRKR's fair value in chart for subscribers.

What is the fair value of BRKR stock?

You can check BRKR's fair value in chart for subscribers. The fair value of Bruker Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Bruker Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for BRKR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Bruker Corp a good stock to buy?

The fair value guage provides a quick view whether BRKR is over valued or under valued. Whether Bruker Corp is cheap or expensive depends on the assumptions which impact Bruker Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BRKR.

What is Bruker Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 18 2024, BRKR's PE ratio (Price to Earnings) is 25.3 and Price to Sales (PS) ratio is 3.65. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BRKR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Bruker Corp's stock?

In the past 10 years, Bruker Corp has provided 0.144 (multiply by 100 for percentage) rate of return.